The overall laparoscopic instruments market is expected to grow from USD 7.61 billion by 2016 to USD 11.68 billion in 2021, at a CAGR of 8.9% from 2017 to 2022. The key factors driving the growth of this market are rising prevalence of colorectal cancer which can be treated laparoscopically, increasing use of laparoscopy for bariatric surgeries, and technological advancements in laparoscopic instruments. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.
The global laparoscopic instruments market is dominated by Karl Storz GmbH & Co. KG (Germany), Olympus Corporation (Japan), Medtronic plc (Ireland), B. Braun Aesculap (Germany), and Stryker Corporation (U.S.). These players jointly commanded approximately ~50% to 60% of the laparoscopic instruments market in 2015.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130019497
Karl Storz GmbH & Co. KG accounted for the largest share of the laparoscopic instruments market. The company offers more than 5,500 products developed in collaboration with users for a range of diagnostic and surgical procedures in the field of laparoscopy. The company’s large product portfolio has helped position it as a market leader. The company has a strong global network and a direct sales force as well as a well-established distributor network across the globe. Through its subsidiaries, the company also provides local-level services to its customers. The company concentrates on strategic expansions to fortify its presence in new or existing markets. For instance, in October 2013, the company opened a new visiting and training center in Berlin to support medical equipment users through lectures, live surgeries, and endoscopy training sessions using the firm’s equipment. The new facility aims to complement the firm’s services, strengthen its network, and improve its relationship with its customers. The company dominates the laparoscopic instruments market and aims to increase its outreach in the market through strategic expansions.
Olympus Corporation is another major player in the laparoscopic instruments market. The company is primarily a key player in the endoscopy equipment market due to its wide range of gastrointestinal endoscope offerings. However, the company has strengthened its position in the laparoscopic instruments market in recent years following the launch of its THUNDER BEAT Energy Device (launched in 2012) and the 3D Laparoscopy Surgical System (launched in 2013). Due to the superior performance of THUNDERBEAT, the company has captured 15% of the global market share in energy devices (Source: Company Annual Report 2015). The launch of the 3D laparoscope in 2013 further strengthened the position of the company in the laparoscopic instruments market. The introduction of these innovative products developed by Olympus Corporation into the market has enabled it to capture a large share of the market.
Medtronic plc (Ireland) has strengthened its position in the laparoscopic instruments market following the acquisition of Covidien plc (Ireland) in January 2015. The acquisition of Covidien bolstered the ‘Minimally Invasive Therapies Group’ of Medtronic formed through the inclusion of a majority of Covidien plc’s former operations. As a result of the acquisition, Medtronic expanded its product portfolio in the areas of surgical care products and energy devices. The company also acquired Smith & Nephew’s gynecology (GYN) business with the aim of expanding its product offerings for women with abnormal uterine bleeding (AUB). The strong performance of the group in stapling devices and energy products has resulted in the growth of the net sales of surgical solutions and has positioned the company among the leading players in the global laparoscopic instruments market. Medtronic is a major competitor to Olympus Corporation in the energy devices segment.
Know More:
https://www.marketsandmarkets.com/Market-Reports/laparoscopic-instruments-market-130019497.html
